The skin serves as the body's primary defense against harmful microorganisms, toxins, and physical damage. However, severe ...

YAVNE, Israel - MediWound Ltd. (NASDAQ:MDWD), a biopharmaceutical company specializing in enzymatic therapies for tissue repair, has launched a Phase III clinical trial for its product EscharEx®, ...

Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closureInterim analysis planned ...

Silver Wound Dressings Market 2032 Rise in prevalence of sport-related injuries & road accidents, and surge in the geriatric population hav ...

As home health providers increasingly serve people with more complicated and serious conditions, and the push for ...

Leaders from the healthcare, regulatory, and wound care sectors will converge in Grapevine, Texas, on Friday, May 2, for the ...

Growth in Interventional Urology was negatively impacted by a voluntary product recall in Bladder Health and Surgery (around DKK 25 million in Q1), partly offset by solid performance in Endourology.

December 2024 Coloplast delivered 8% organic growth and an EBIT margin1 of 27% in Q1, in line with expectations. Reported ...

According to a new market research report titled, 'Burn Care Market Size, Share, Forecast, & Trends Analysis by Offering (Topical Agents, Dressings ...

According to a new market research report titled, 'Burn Care Market Size, Share, Forecast, & Trends Analysis by Offering ...

Introduction Wound debridement is a critical medical procedure used to treat various types of wounds, including burns, <a target=_blank href= ...